Waldencast PLC (NASDAQ:WALD – Get Free Report) was the recipient of a significant growth in short interest during the month of March. As of March 13th, there was short interest totaling 1,205,249 shares, a growth of 61.6% from the February 26th total of 745,941 shares. Approximately 0.9% of the shares of the company are short sold. Based on an average daily trading volume, of 69,706 shares, the days-to-cover ratio is presently 17.3 days.
Analysts Set New Price Targets
A number of equities analysts recently issued reports on WALD shares. Jefferies Financial Group started coverage on Waldencast in a research note on Wednesday, January 14th. They issued a “buy” rating and a $2.00 target price for the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Waldencast in a research note on Wednesday, January 21st. Canaccord Genuity Group cut their price objective on Waldencast from $4.00 to $2.00 and set a “buy” rating on the stock in a report on Monday, March 16th. Finally, Telsey Advisory Group reduced their price objective on Waldencast from $3.00 to $2.00 and set a “market perform” rating for the company in a research note on Monday, March 16th. Three equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Waldencast presently has a consensus rating of “Hold” and a consensus target price of $3.20.
Get Our Latest Stock Report on WALD
Institutional Investors Weigh In On Waldencast
Waldencast Stock Performance
Shares of Waldencast stock opened at $0.98 on Friday. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.70 and a quick ratio of 0.97. The firm has a fifty day moving average price of $1.62 and a 200 day moving average price of $1.85. Waldencast has a 1 year low of $0.98 and a 1 year high of $3.22.
About Waldencast
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. The company also offers clean makeup products under the Milk Makeup brand. It sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners.
Featured Stories
Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.
